Mazar-i-Sharif (CBD): A Comprehensive Strain Guide

Origins and Historical Context

Mazar-i-Sharif (CBD) traces its roots to the storied cannabis fields around the city of Mazar-e-Sharif in northern Afghanistan, a region synonymous with dense, resin-heavy indica landraces. For generations, farmers in the Balkh province selected plants for copious trichome production to make traditional sieved hash, resulting in cultivars famed for their thick, sticky resin heads. These regional selections adapted to a continental, semi-arid climate with scorching summers, cool nights, and low humidity—a terroir that consistently rewarded stocky, broadleaf morphologies and robust stalks.

Modern seed companies later introduced Mazar genetics to the West, preserving the hallmark resin output while refining agronomic traits. Dutch-bred Mazar lines, for example, standardized phenotypes for indoor cultivation while maintaining the Afghan backbone known for resilience and hash-grade trichomes. Contemporary “CBD” versions build on this foundation, either through selecting rare high-CBD Afghan expressions or outcrossing to established CBD donors before backcrossing to re-anchor the classic Mazar look and feel.

By the late 20th century, Mazar-derived cultivars had become building blocks for notable hybrids, informing terpene profiles and structure in both THC- and CBD-forward lines. The region’s legacy also influenced plant hardiness—growers often describe Afghani Kush-family cultivars, including Mazar lines, as “tough” and capable of withstanding harsh conditions. In reputable seed catalogs and grower accounts, Mazar’s Afghan origin is cited as central to its reliable performance and heavy resin character.

As legal cannabis markets matured, interest surged in therapeutic chemotypes, catalyzing the development of CBD-dominant or balanced variants of classic strains. The CBD version of Mazar-i-Sharif appeals to consumers seeking the earthy, hash-forward charm of old-school Afghan cannabis with less intoxication. This evolution preserves cultural heritage while aligning with modern wellness-oriented preferences and compliance standards.

Genetic Lineage and Breeding of the CBD Chemotype

The base genetic material behind Mazar-i-Sharif is a traditional Afghan landrace, notable for indica-leaning architecture, broad leaflets, and heavy resin. Dutch Passion’s Mazar—described as a popular old-school hybrid and a direct descendant of original Afghan stock—has anchored many Western breeding projects. While classic Mazar phenotypes are THC-dominant, the CBD version likely emerged from either finding a rare Type II (balanced) or Type III (CBD-dominant) expression in Afghan lines or by crossing Mazar with a proven CBD donor.

CBD chemotype development typically follows two strategies. The first is selection within heterogenous landrace populations, wherein breeders phenotype-hunt for plants showing elevated cannabidivarin or cannabidiol ratios and then stabilize across generations. The second is hybridization to a known CBD source—such as a Type III cultivar—followed by backcrossing to the Mazar parent to reassert the Afghan morphology and terpene signature while retaining CBD dominance.

In the broader Mazar family tree, you can spot its influence in modern hybrids. For example, the LSD strain (by Barneys Farm) crosses Mazar-I-Sharif with Skunk #1, yielding a cultivar with sweet citrus and earth aromas, an indicator of how Mazar’s earthy spice can harmonize with Skunk’s brighter terpenes. Related Dutch Passion staples like Blue Auto Mazar blend Mazar resin traits with autoflowering genetics, maturing in about 70–75 days from germination, evidence of how Mazar lines adapt well to different breeding goals.

The CBD iteration aims to keep iconic Afghan traits—short internodes, bulky colas, and dense trichome coverage—while modulating psychoactivity. Most CBD-centric breeding targets either a 1:1 CBD:THC ratio (Type II) for balanced effects or a CBD-dominant profile with THC below 1% (Type III) to minimize intoxication. In stabilized seed lines, breeders typically report consistent chemotypes across 70–85% of plants, with further uniformity attainable through clonal propagation.

Morphology and Visual Appearance

Mazar-i-Sharif (CBD) exhibits classical Afghan broadleaf indica structure: compact, sturdy, and built to hold weighty flowers. Indoors, heights commonly range from 80–120 cm when untrained, while outdoor plants in favorable climates can hit 150–250 cm with thick central stalks. The branching is symmetrical with short internodes, creating a bushy canopy that lends itself to a uniform top—perfect for sea-of-green (SOG) or screen-of-green (SCROG) setups.

The flowers are notably dense and golf-ball to cola-sized, replete with swollen calyxes and a crowded blanket of glandular trichomes. Mature buds transition from deep forest green to darker olive tones, with rust-orange pistils turning deeper amber as peak ripeness approaches. In cooler nights late in bloom, some phenotypes display anthocyanin expressions that add burgundy or plum hues along sugar leaves.

Trichome coverage is a defining visual characteristic, often giving buds a frosted, almost chalky appearance under light. Under magnification, resin heads are typically well-formed and bulbous, with stalked capitate trichomes dominating. This resin saturation reflects the cultivar’s hash-making lineage, correlating with high extraction yields by dry sift or ice water separation.

Leaf morphology skews toward the classic indica—broad, thick blades with dark, glossy green coloration. Petioles are stout, and the plant’s overall posture is compact but powerful, hinting at the robust lignin content in stems and branches. Growers often note minimal need for excessive support indoors, though trellising can improve light penetration and prevent compression of dense flowers late in bloom.

Aroma and Flavor Profile

The aroma of Mazar-i-Sharif (CBD) is rich, earthy, and reminiscent of traditional Afghan hash, with base notes of fresh soil, sandalwood, and warm spice. Sweet, resinous undertones introduce impressions of incense and dried flowers, creating a layered bouquet that deepens as the flowers cure. Many phenotypes also present peppery and woody nuances linked to beta-caryophyllene and humulene.

Upon grind, you may encounter a burst of herbal-musk from myrcene, mingling with subtle lavender-like florals from linalool. Some phenos, especially those with slight hybrid influence, reveal restrained citrus-zest top notes, a hint that limonene is present even if not dominant. While not overtly fruity, the overall scent is complex and persistent, with a “hash cellar” quality that intensifies over time.

Flavor echoes these aromatic signatures. Expect an earthy inhale with sandalwood and nutty-spice, followed by pepper and herbal-musk on the exhale. The aftertaste is long, slightly sweet, and incense-like, often lingering on the palate for several minutes after consumption.

The influence of Mazar’s genetics in hybridizations further illustrates its terpene potential. In LSD (Mazar-I-Sharif x Skunk #1), citrus and earthy elements interplay prominently, indicating that the Mazar base readily accommodates brighter terpenes when crossed. In the CBD version, however, the earth-incense core tends to remain dominant, offering a calming, old-world flavor profile prized by traditionalists and medical users alike.

Cannabinoid Composition and Potency (CBD Focus)

CBD-oriented Mazar-i-Sharif typically appears in two chemotypes. The first is Type II, a balanced profile hovering around a 1:1 CBD:THC ratio—often 6–10% CBD with 5–9% THC and total cannabinoids in the 12–18% range. The second is Type III, CBD-dominant with THC at or below 1% and CBD commonly between 10–18%, delivering minimal intoxication and a pronounced body calm.

In licensed markets, third-party certificates of analysis (COAs) frequently report total CBD and THC alongside minor cannabinoids like CBC, CBG, and THCV. In CBD-dominant plants, CBG often measures around 0.2–1.0%, and CBC may appear in trace to ~0.5%, with trace THCV occasionally noted. Total cannabinoid content in well-grown flowers can range from 12–22% in aggregate, depending on genotype and cultivation conditions.

For inhaled products, users generally report felt onset within 5–10 minutes, with peak effects between 20–40 minutes and a duration of about 2–3 hours. Oral products, such as infused oils or edibles, have slower onsets, commonly 45–120 minutes, with durations lasting 4–6 hours or longer. These timeframes can vary based on dose, metabolism, fed/fasted state, and method of delivery.

CBD is non-intoxicating at common doses, although a Type II Mazar-i-Sharif (CBD) will exhibit mild euphoria due to THC presence. Many users target daily CBD intakes within the 5–50 mg range for general wellness, with higher medical doses deployed under clinical guidance. As always, consumers should consult product COAs to align cannabinoid content with desired effects and personal tolerance.

Terpene Profile and Aroma Chemistry

The terpene profile of Mazar-i-Sharif (CBD) is typically myrcene-forward, backed by beta-caryophyllene, humulene, and a supporting cast of linalool, limonene, and pinene. In many samples, total terpene concentration ranges from 1.0–3.0% by dry weight, with top-tier batches occasionally surpassing 3.5%. Myrcene often falls between 0.6–1.2%, beta-caryophyllene between 0.3–0.7%, and humulene in the 0.1–0.3% band.

Linalool is a frequent secondary terpene in Afghan-derived cultivars and is associated with calming, indica-leaning experiences. Strains rich in linalool often impart mental and physical relaxation—consistent with Mazar’s reputation for soothing body effects. Limonene, usually present at 0.1–0.3%, contributes understated citrus lift that brightens the otherwise earthy-spicy bouquet.

Beta-caryophyllene is unique as a dietary cannabinoid that can bind to the CB2 receptor, potentially modulating inflammatory processes. Its peppery, woody spice is readily apparent in the Mazar mouthfeel and retrohale. Humulene contributes to the woody-herbal notes and has been studied for potential anti-inflammatory properties, complementing CBD’s profile in wellness-oriented products.

Pinene (often 0.05–0.15%) adds a thread of forest-fresh sharpness and may counteract some sedative qualities by supporting alertness, though it remains a background player in this cultivar. The overall synergy—sometimes called the entourage effect—derives from how these terpenes align with cannabinoids to shape perceived effects. This chemical chorus gives Mazar-i-Sharif (CBD) its signature hashy aroma and calming, grounded presence.

Experiential Effects and Functional Use

Mazar-i-Sharif (CBD) is best described as calming, body-centered, and steadying, with a clear head at CBD-dominant ratios. Users commonly report muscle ease, reduced somatic tension, and a gentle mood lift without overwhelming psychoactivity. In Type II expressions with 1:1 ratios, there may be a mild, comfortable euphoria layered over the body calm.

The onset via inhalation is typically smooth and quick, with muscle relaxation evident in the first 10–20 minutes. The experience is often described as “unclenching,” with shoulders and jaw relaxing and a quieting of background stress. Focus is usually intact at moderate doses, making it suitable for reading, light conversation, or winding down after work.

At higher doses—especially in evening use—sedation can surface, likely aided by myrcene and linalool. This makes the cultivar appealing for easing into sleep routines, though users should assess personal tolerance before bedtime. Individuals sensitive to THC may prefer Type III phenotypes or low-THC extracts to keep cognition crisp.

Compared to THC-heavy Afghan indicas, the CBD variant is gentler and more functional for daytime relief. Many note an absence of racy or anxious edges, which can be helpful for those who find high-THC strains overstimulating. Overall, Mazar-i-Sharif (CBD) shines as a reliable, grounding option for stress modulation and physical comfort.

Potential Therapeutic Applications

CBD has been investigated across numerous indications, lending Mazar-i-Sharif (CBD) practical relevance in wellness and symptom management. Randomized and open-label studies of CBD-rich preparations report reductions in anxiety measures, and many patients anecdotally use 10–50 mg daily for generalized stress. Importantly, FDA-approved CBD (Epidiolex) demonstrated median seizure reductions of about 36–43% in Lennox–Gastaut and Dravet syndromes, underscoring CBD’s anticonvulsant potential in clinical contexts.

Pain and inflammation are recurring themes in user reports with CBD-forward cultivars. Beta-caryophyllene’s activity at CB2 receptors, coupled with CBD’s broad immunomodulatory profile, may contribute to perceived relief in inflammatory discomforts. Myrcene and linalool add sedative and muscle-relaxant dimensions that some patients find helpful for tension headaches and post-exertion soreness.

Sleep quality can improve indirectly through reductions in anxiety and muscle tension, though CBD’s direct effects on sleep are nuanced and dose-dependent. Lower doses (e.g., 10–25 mg) may promote calm without heavy sedation, while higher doses, in some individuals, can be activating. For those seeking sleep support, the myrcene- and linalool-rich nature of Mazar-i-Sharif (CBD) flower may complement bedtime routines when used responsibly.

For mood and stress, many consumers report a re-centering effect with reduced irritability and fewer somatic stress signals. When THC is present at balanced ratios, some lift in mood or hedonic tone can appear, which some patients find helpful for low motivation. As with all cannabis use, patients should consult healthcare professionals, especially when taking medications metabolized by CYP450 enzymes, as CBD can impact their metabolism.

Cultivation Guide for Legal Growers

Note: Cultivation should only be undertaken where it is lawful to do so. The following information is intended for compliant, licensed, or personal-use growers in legal jurisdictions. Always follow local regulations regarding plant counts, licensing, and cultivation practices.

Growth habit and vigor: Mazar-i-Sharif (CBD) typically grows compact and bushy with strong central stems and rapid early vegetative growth. Indoors, an untrained height of 80–120 cm is common, with significant lateral branching that responds well to topping, SCROG, or SOG. Outdoors, expect 150–250 cm in temperate climates with full sun and well-drained soils.

Environment: In vegetative growth, target 22–28°C day temperatures with 55–65% relative humidity. During flowering, maintain 20–26°C with RH gradually tapered to 40–50%, then 35–45% in late bloom to minimize Botrytis risk in dense colas. A moderate VPD aligned with these ranges promotes steady transpiration and reduces microclimate humidity within the canopy.

Lighting: Photoperiod plants perform well under 18/6 in veg and 12/12 in flower, with PPFD targets of 350–600 μmol/m²/s in veg and 600–900 μmol/m²/s in flower. Many growers find 800–900 μmol/m²/s optimal for dense Afghan-style flowers, provided CO2 and nutrition are adequate. Outdoors, a daily light integral (DLI) of 35–55 mol/m²/day supports high-yield outcomes.

Media and pH: In soil or soilless blends, maintain pH 6.2–6.8; in hydro or coco, aim for pH 5.7–6.1. Electrical conductivity (EC) can range ~1.2–1.6 mS/cm in veg and 1.6–2.0 mS/cm in mid-flower for vigorous phenotypes, tapering slightly late. Afghan-derived plants appreciate ample calcium and magnesium; consider a Ca:Mg ratio near 3:1 and supplement as needed to prevent tip burn or interveinal chlorosis.

Nutrition: Provide moderate-to-high nitrogen in early veg, then transition to a phosphorus- and potassium-forward bloom regimen. Many growers implement PK boosts around weeks 4–6 of flower, avoiding overfeeding that can reduce terpene intensity. Keep an eye on micronutrient balance; sulfur supports te